Cite
Masi M, Garattini E, Bolis M, et al. OXER1 and RACK1-associated pathway: a promising drug target for breast cancer progression. Oncogenesis. 2020;9(12):105doi: 10.1038/s41389-020-00291-x.
Masi, M., Garattini, E., Bolis, M., Di Marino, D., Maraccani, L., Morelli, E., Grolla, A. A., Fagiani, F., Corsini, E., Travelli, C., Govoni, S., Racchi, M., & Buoso, E. (2020). OXER1 and RACK1-associated pathway: a promising drug target for breast cancer progression. Oncogenesis, 9(12), 105. https://doi.org/10.1038/s41389-020-00291-x
Masi, Mirco, et al. "OXER1 and RACK1-associated pathway: a promising drug target for breast cancer progression." Oncogenesis vol. 9,12 (2020): 105. doi: https://doi.org/10.1038/s41389-020-00291-x
Masi M, Garattini E, Bolis M, Di Marino D, Maraccani L, Morelli E, Grolla AA, Fagiani F, Corsini E, Travelli C, Govoni S, Racchi M, Buoso E. OXER1 and RACK1-associated pathway: a promising drug target for breast cancer progression. Oncogenesis. 2020 Dec 11;9(12):105. doi: 10.1038/s41389-020-00291-x. PMID: 33311444; PMCID: PMC7732991.
Copy
Download .nbib